| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000000707 |
| Receipt No. | R000000842 |
| Official scientific title of the study | Japanese Aortic Stenosis Study |
| Date of disclosure of the study information | 2007/05/07 |
| Last modified on | 2016/05/05 (Ver. 15) |
| Basic information | ||
| Official scientific title of the study | Japanese Aortic Stenosis Study | |
| Title of the study (Brief title) | JASS | |
| Region |
|
|
| Condition | ||
| Condition | aortic valve stenosis or calcification | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clarify
1) factors related to the progression of aortic valve stenosis or calcification 2) the natural course of aortic valve stenosis or calcification 3) effective therapeutic approaches |
| Basic objectives2 | Others |
| Basic objectives -Others | This is an observational study |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | 1) Severity of aortic stenosis or calcification assessed by echocardiography
2) Clinical events or symptoms for 3 years |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | transaortic valve velocity > or = 2m/s
or leaflet calcification of aortic valve |
|||
| Key exclusion criteria | 1, rheumatic valve changes
2, post-operation of aortic valve 3, scheduled aortic valve operation 4, not suitable to this study (a doctor decides) |
|||
| Target sample size | 300 | |||
| Research contact person | |
| Name of lead principal investigator | kazuhiro Yamamoto |
| Organization | Tottori University, Faculty of Medicine |
| Division name | The Department of Molecular Medicine and Therapeutics |
| Address | 86 Nishi-cho, Yonago, 683-8503, Japan |
| TEL | 0859-38-6517 |
| ykazuhiro@med.tottori-u.ac.jp | |
| Public contact | |
| Name of contact person | kazuhiro Yamamoto |
| Organization | Tottori University, Faculty of Medicine |
| Division name | The Department of Molecular Medicine and Therapeutics |
| Address | 86 Nishi-cho, Yonago, 683-8503, Japan |
| TEL | 0859-38-6517 |
| Homepage URL | |
| ykazuhiro@med.tottori-u.ac.jp | |
| Sponsor | |
| Institute | Tottori University |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | the Ministry of Health, Labour and Welfare |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | Japan Heart Foundation |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | The results of the retrospective analysis were published in Hypertens Res 2010 ;33:269-74.
The results of the prospective analysis were published in Circ J 2015;79:2050-7 |
| Other related information | This study consists of JASS (retrospective and prospective studies). |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000000842 |